High success rate of cervical ripening with Dilapan-S®
International observational E-registry Study was monitoring clinical outcomes of the use of the synthetic osmotic dilator Dilapan–S® for cervical ripening prior to induction of labor.
444 eligible subjects were enrolled in 11 study sites worldwide.
The study contained nulliparas, multiparas, as well as mothers with previous C. section.
Efficacy Outcomes of Dilapan-S®
Mean gain of Bishop score + 3,6
Cervical ripening achieved in 94,4 %
Rate of vaginal delivery 70 %*
* vaginal delivery rate varied between 51-83% depending on study center
The use of Dilapan-S® leads to succesful cervical ripening in almost 95% of women
High vaginal delivery rate with Dilapan-S®
A randomized controlled trial of Dilapan-S® versus Foley Balloon – called DILAFOL Trial, was monitoring efficacy, safety and patient satisfaction parameters for usage of Dilapan-S® in labor induction.
419 women were randomized from November 2016 to February 2018 in University of Texas Medical Branch, Galveston, Texas, USA
CERVICAL RIPENING SUCCESS RATE WITH 1st ROUND OF DILATOR
Both products reached excellent rate of successful ripening
% of women needed another intervention for ripening was only 1,5% in Dilapan-S group and 0,5% in Foley group,resp.
VAGINAL DELIVERY RATE
CAESAREAN SECTION RATE
The use of Dilapan–S® leads to vaginal delivery in more than 81% of cases
No limitation related to mother’s gestational age or comorbidities with Dilapan-S®
In multiple studies, Dilapan-S® was used also for high-risk groups of patients with no related complications or side effects.
Many of these complications represent relative contraindications for usage of prostaglandines.
- Postterm pregnancies
- Gestational Diabetes Mellitus
- Previous Cesarean section